Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine

      Drug Development
      Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc., the leading global provider of advanced delivery...

      Vaxart Announces Additional Positive Pre-Clinical Data for its Oral COVID-19 Vaccine Program

      Clinical Trials
      Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has obtained...

      Trio pharmaceuticals and ajinomoto bio pharma services enter into a development collaboration for a novel antibody therapeutic

      Drug Development
      Trio Pharmaceuticals, Inc., a cancer therapeutics company developing novel dual action antibody drugs, and Ajinomoto Bio-Pharma Services, have entered a development collaboration to evaluate...

      GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 Vaccine Development

      Drug Development
      GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced that Beijing- and Philadelphia-based Sino Biological, Inc....

      Quotient Limited Announces CE Mark for its SARS-CoV-2 Antibody Microarray

      FDA Approvals
      Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced that it has completed the process for declaring conformity to the essential requirements...

      ProteoGenix to accelerate the discovery of SARS-CoV-2 antibodies with first human immune COVID-19 library

      Drug Development
      ProteoGenix, a global leader in antibody production, is pleased to announce the first Human Immune COVID-19 library for the fast discovery of potent antibodies...

      Fujifilm Diosynth Biotechnologies Teams with COVID-19 Therapeutics Accelerator

      Drug Development
      FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), today announced that it will reserve manufacturing capacity for a future COVID-19...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      © 2025 Copyright © Valuemediaservices 2025 All rights reserved.